Tandem Meetings offered ‘a lot of variety,’ including CAR-T, AI

In this video, Albert C. Yeh, MD, discusses use of chimeric antigen receptor T-cell therapy for autoimmune diseases, one of many topics covered at Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR.
“That’s quite fascinating because there’s actually more cases of autoimmune diseases than there are cancer cases that are treatable with CAR T cells,” Yeh, physician and research associate of Translational Science and Therapeutics at Fred Hutch Cancer Center and acting assistant professor at the University of Washington School of Medicine,